Coats A C, Jenkins H A, Monroe B
Am J Otol. 1984 Oct;5(6):443-6.
With an expanded clinical and normative SP amplitude series, we have re-examined the incidence of SP enlargement in clinically defined Meniere and cochlear ears. The overall incidence of SP enlargement in the expanded series is somewhat less than that found in our previous study (56% versus 68%). This difference may be due to considerable preselection of patients included in the previous smaller clinical population, since many of these patients were recruited for the study because of diagnosed Meniere's disease. In contrast, the present, larger clinical population was selected from our normal service referral base, and thus contains a much higher percentage of diagnostic problems. The comparison between SP enlargement and hearing levels demonstrates that the SP test for Meniere's disease must be interpreted in the light of high-frequency hearing levels. If the patient has normal or near-normal hearing (4- to 8-kHz hearing levels 25 dB or less), SP enlargement will not be a good criterion for detecting the presence of Meniere's disease. Gibson and colleagues and Kumagami and associates have reported similar observations. Also, in the presence of severe high-frequency hearing loss (above about 70 dB), SP enlargement occurs relatively infrequently among ears with clinical diagnoses of Meniere's disease. However, in the mid-range (25 to 70 dB) of high-frequency loss, SP enlargement appears to provide a reasonably accurate test for Meniere's disease (with a "hit rate" among clinically defined Meniere ears of about 71%).(ABSTRACT TRUNCATED AT 250 WORDS)
通过扩大临床和正常的总和电位(SP)幅度系列,我们重新检查了临床确诊的梅尼埃病和耳蜗疾病中SP扩大的发生率。在扩大系列中,SP扩大的总体发生率略低于我们之前的研究(56%对68%)。这种差异可能是由于之前较小临床群体中患者的大量预先选择,因为这些患者中有许多是因被诊断为梅尼埃病而被招募参加研究的。相比之下,目前较大的临床群体是从我们的正常服务转诊基础中选取的,因此包含更高比例的诊断问题。SP扩大与听力水平之间的比较表明,梅尼埃病的SP测试必须根据高频听力水平来解释。如果患者听力正常或接近正常(4至8千赫听力水平为25分贝或更低),SP扩大将不是检测梅尼埃病存在的良好标准。吉布森及其同事以及熊上及其同事也报告了类似的观察结果。此外,在存在严重高频听力损失(约70分贝以上)的情况下,临床诊断为梅尼埃病的耳朵中SP扩大相对较少发生。然而,在高频损失的中范围(25至70分贝),SP扩大似乎为梅尼埃病提供了一个相当准确的测试(临床确诊的梅尼埃病耳朵中的“命中率”约为71%)。(摘要截断于250字)